Auxilium files Xiaflex for Dupuytren's contracture in the US
This article was originally published in Scrip
Executive Summary
Auxilium Pharmaceuticals has filed a BLA with the US FDA for its investigational first-in-class treatment, Xiaflex (clostridial collagenase for injection), for Dupuytren's contracture.